中东和非洲睡眠障碍治疗市场规模、趋势、增长报告 2028

中东和非洲睡眠障碍治疗市场，按类型（失眠、睡眠呼吸暂停、不宁腿综合征 (RLS)、发作性睡病等）、治疗（药物治疗、机械治疗、下颌推进装置、舌下神经刺激器、手术等）、给药途径（口服、肠胃外等）、药物类型（品牌药和仿制药）、人群类型（儿童和成人）、最终用户（医院、专科诊所、家庭医疗保健、门诊手术中心等）、分销渠道（直接招标、医院药房、零售药房、网上药房等）、国家（南非、沙特阿拉伯、阿联酋、埃及、科威特、以色列、中东和非洲其他地区）划分的行业趋势和预测到 2028 年

市场分析与洞察：中东和非洲睡眠障碍治疗市场

睡眠障碍治疗市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场以 7.0% 的复合年增长率增长，预计到 2028 年将达到 3.7283 亿美元。全球范围内睡眠呼吸暂停、失眠和嗜睡症等睡眠障碍患病率的增加正在推动睡眠障碍治疗市场的发展。

睡眠障碍，例如睡眠呼吸暂停、嗜睡症或失眠症，是一种医学障碍，患者难以维持睡眠或入睡。这种疾病会导致精神、身体、社交和情绪功能紊乱。根据患者的症状，睡眠障碍可通过不同的治疗方法进行治疗。大多数睡眠呼吸暂停患者通过机械疗法进行治疗。

睡眠障碍的增加将增加对睡眠障碍治疗方案的需求。因此，由于忙碌的生活和不良习惯而导致的精神压力增加预计将推动睡眠障碍治疗市场的增长。副作用的程度可能危及生命，导致患者对消费产生恐惧，从而导致销售和需求下降。因此，药物的不良反应是睡眠障碍治疗市场增长的制约因素。技术进步的不断进步为促进睡眠障碍治疗市场的需求提供了机会。睡眠障碍治疗的高成本对睡眠障碍治疗市场的增长构成了挑战。

睡眠障碍治疗市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和睡眠障碍治疗市场情况，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预期目标。

睡眠障碍治疗市场范围和市场规模

睡眠障碍治疗市场根据类型、治疗、给药途径、药物类型、人群类型、最终用户和分销渠道分为七个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

根据类型，睡眠障碍治疗市场分为失眠、睡眠呼吸暂停、不安腿综合征 (RLS)、发作性睡病等。2021 年，失眠症领域预计将占据睡眠障碍治疗市场的主导地位，因为技术进步将为特定疾病开发创新的治疗方案。
根据治疗方式，睡眠障碍治疗市场分为药物治疗、机械治疗、下颌推进装置、舌下神经刺激器、手术等。2021 年，药物治疗领域预计将主导睡眠障碍治疗市场，因为根据患者的症状，有许多类别的药物可用于治疗睡眠障碍。
根据给药途径，睡眠障碍治疗市场分为口服、肠外和其他。2021 年，口服药物预计将在睡眠障碍治疗市场占据主导地位，因为用于治疗发作性睡病、不安腿综合征 (RLS) 和失眠等睡眠障碍的口服药物越来越多。
根据药物类型，睡眠障碍治疗市场分为品牌药和仿制药。2021 年，仿制药市场预计将主导睡眠障碍治疗市场，因为用于治疗睡眠障碍的仿制药（如加巴喷丁、唑吡坦缓释片和右佐匹克隆片、CIV 等）的供应增加。
根据人口类型，睡眠障碍治疗市场分为儿童和成人。由于全球老年人口激增，需要更先进的治疗方案，预计到 2021 年，成人群体将主导睡眠障碍治疗市场。
根据最终用户，睡眠障碍治疗市场分为医院、专科诊所、家庭医疗保健、门诊手术中心和其他。2021 年，医院部门预计将主导睡眠障碍治疗市场，因为医院有财力购买手术中使用的昂贵设备，并且有训练有素的专业人员操作机械设备和处方药。
根据分销渠道，睡眠障碍治疗市场分为直接招标、医院药房、零售药房、网上药房和其他。2021 年，直接招标市场预计将主导睡眠障碍治疗市场，因为大多数药品都是通过直接招标服务采购的。

中东和非洲睡眠障碍治疗市场国家级分析

对中东和非洲睡眠障碍治疗市场进行了分析，并按上述国家、类型、治疗、给药途径、药物类型、人口类型、最终用户和分销渠道提供了市场规模信息。

中东和非洲睡眠障碍治疗市场报告涉及的国家包括南非、沙特阿拉伯、阿联酋、埃及、科威特、以色列以及中东和非洲其他地区。

沙特阿拉伯凭借其技术进步以及该地区睡眠障碍治疗主要参与者的存在，在中东和非洲睡眠障碍治疗市场占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了中东和非洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。

制造商推出的新产品为睡眠障碍治疗市场参与者创造了新的机会

睡眠障碍治疗市场还为您提供了每个国家美容行业增长的详细市场分析，包括睡眠障碍治疗市场的销售、睡眠障碍治疗市场发展的影响以及监管环境的变化及其对睡眠障碍治疗市场的支持。数据涵盖 2011 年至 2019 年的历史时期。

竞争格局和睡眠障碍治疗市场份额分析

睡眠障碍治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对睡眠障碍治疗市场的关注有关。

中东和非洲睡眠障碍治疗市场报告涵盖的主要参与者包括 Jazz Pharmaceuticals, Inc.、Pfizer Inc.、Viatris Inc.、Hikma Pharmaceuticals PLC、Taj Pharmaceuticals Limited、Mallinckrodt、Alembic Pharmaceuticals Limited、Dr. Reddy's Laboratories Ltd.、Koninklijke Philips NV、ResMed 以及其他国内参与者。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。

全球各地的公司也推出了许多产品并达成了多项协议，这也加速了睡眠障碍治疗市场的发展。

例如，

2020年9月，Jazz Pharmaceuticals, Inc.宣布与美国心脏协会的睡眠健康教育内容合作，以加强其睡眠健康治疗领域。该公司的这一新合作提高了其在市场上的可信度。

市场参与者的合作、合资和其他策略正在增强公司在睡眠障碍治疗市场中的市场，这也为组织改善其睡眠障碍治疗服务提供了好处。

SKU-59669

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

LIST OF TABLES

TABLE 1 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: PIPELINE ANALYSIS

TABLE 2 GENERIC DRUGS FOR SLEEP DISORDER TREATMENT

TABLE 3 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 6 MIDDLE EAST AND AFRICA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 7 MIDDLE EAST AND AFRICA SLEEP SPNEA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 8 MIDDLE EAST AND AFRICA RESTLESS LEGS SYNDROME (RLS) IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 9 MIDDLE EAST AND AFRICA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 10 MIDDLE EAST AND AFRICA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 11 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT, 2018-2028 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 13 MIDDLE EAST AND AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 14 MIDDLE EAST AND AFRICA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 15 MIDDLE EAST AND AFRICA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 16 MIDDLE EAST AND AFRICA MANDIBULAR ADVANCEMENT DEVICES IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 17 MIDDLE EAST AND AFRICA HYPOGLOSSAL NERVE STIMULATOR IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 18 MIDDLE EAST AND AFRICA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 19 MIDDLE EAST AND AFRICA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 20 MIDDLE EAST AND AFRICA OTHERS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 21 MIDDLE EAST AND AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 24 MIDDLE EAST AND AFRICA PARENTERAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 25 MIDDLE EAST AND AFRICA OTHERS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 26 MIDDLE EAST AND AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA GENERICS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 28 MIDDLE EAST AND AFRICA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 30 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE, 2018-2028 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA ADULT IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 32 MIDDLE EAST AND AFRICA CHILDREN IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 33 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY END USER, 2018-2028 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA HOSPITALS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 35 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 36 MIDDLE EAST AND AFRICA HOME HEALTHCARE IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 37 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTER IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 38 MIDDLE EAST AND AFRICA OTHERS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 39 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2028 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA DIRECT TENDER IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 41 MIDDLE EAST AND AFRICA HOSPITAL PHARMACY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 42 MIDDLE EAST AND AFRICA RETAIL PHARMACY IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 43 MIDDLE EAST AND AFRICA ONLINE PHARMACY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 44 MIDDLE EAST AND AFRICA HOSPITALS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 45 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 52 MIDDLE EAST AND AFRICA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 53 MIDDLE EAST AND AFRICA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 55 MIDDLE EAST AND AFRICA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 56 MIDDLE EAST AND AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 57 MIDDLE EAST AND AFRICA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 58 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 59 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 60 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 61 SOUTH AFRICA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 62 SOUTH AFRICA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 63 SOUTH AFRICA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 64 SOUTH AFRICA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 65 SOUTH AFRICA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 66 SOUTH AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 67 SOUTH AFRICA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 68 SOUTH AFRICA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 69 SOUTH AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 70 SOUTH AFRICA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 71 SOUTH AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 72 SOUTH AFRICA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 73 SOUTH AFRICA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 74 SOUTH AFRICA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 75 SOUTH AFRICA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 76 SAUDI ARABIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 77 SAUDI ARABIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 SAUDI ARABIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 79 SAUDI ARABIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 80 SAUDI ARABIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 81 SAUDI ARABIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 82 SAUDI ARABIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 83 SAUDI ARABIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 84 SAUDI ARABIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 85 SAUDI ARABIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 86 SAUDI ARABIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 87 SAUDI ARABIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 88 SAUDI ARABIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 89 SAUDI ARABIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 90 SAUDI ARABIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 91 UAE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 92 UAE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 93 UAE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 94 UAE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 95 UAE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 96 UAE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 97 UAE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 98 UAE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 99 UAE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 100 UAE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 101 UAE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 102 UAE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 103 UAE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 104 UAE SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 105 UAE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 106 EGYPT SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 107 EGYPT INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 108 EGYPT SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 109 EGYPT NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 110 EGYPT SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 111 EGYPT PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 112 EGYPT MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 113 EGYPT SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 114 EGYPT PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 115 EGYPT ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 116 EGYPT PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 117 EGYPT BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 118 EGYPT SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 119 EGYPT SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 120 EGYPT SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 121 KUWAIT SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 122 KUWAIT INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 123 KUWAIT SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 124 KUWAIT NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 125 KUWAIT SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 126 KUWAIT PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 127 KUWAIT MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 128 KUWAIT SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 129 KUWAIT PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 130 KUWAIT ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 131 KUWAIT PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 132 KUWAIT BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 133 KUWAIT SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 134 KUWAIT SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 135 KUWAIT SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 136 ISRAEL SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 137 ISRAEL INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 138 ISRAEL SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 139 ISRAEL NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 140 ISRAEL SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 141 ISRAEL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 142 ISRAEL MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 143 ISRAEL SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 144 ISRAEL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 145 ISRAEL ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 146 ISRAEL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 147 ISRAEL BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 148 ISRAEL SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 149 ISRAEL SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 150 ISRAEL SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 151 REST OF MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET , BY TYPE 2019-2028 (USD MILLION)

图片列表

LIST OF FIGURES

FIGURE 1 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: MARKET END USER COVERAGE GRID

FIGURE 10 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: SEGMENTATION

FIGURE 11 RISING PREVALENCE OF SLEEPING DISORDERS IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 INSOMNIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET

FIGURE 14 PROPORTION OF AMERICAN TWEENS (8- TO 12- YEAR-OLD) SPENDING TIME WITH SCREEN MEDIA IN A DAY (IN HOURS)

FIGURE 15 PROPORTION OF AMERICAN TEENS (13- TO 18- YEAR-OLD) SPENDING TIME WITH SCREEN MEDIA IN A DAY (IN HOURS)

FIGURE 16 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY TYPE, 2020

FIGURE 17 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY TYPE, 2020-2028 (USD MILLION)

FIGURE 18 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY TYPE, CAGR (2020-2028)

FIGURE 19 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 20 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, 2020

FIGURE 21 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, 2020-2028 (USD MILLION)

FIGURE 22 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, CAGR (2020-2028)

FIGURE 23 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, LIFELINE CURVE

FIGURE 24 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020

FIGURE 25 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)

FIGURE 26 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)

FIGURE 27 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 28 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, 2020

FIGURE 29 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, 2020-2028 (USD MILLION)

FIGURE 30 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, CAGR (2020-2028)

FIGURE 31 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, LIFELINE CURVE

FIGURE 32 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, 2020

FIGURE 33 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, 2020-2028 (USD MILLION)

FIGURE 34 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, CAGR (2020-2028)

FIGURE 35 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, LIFELINE CURVE

FIGURE 36 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY END USER, 2020

FIGURE 37 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY END USER, 2020-2028 (USD MILLION)

FIGURE 38 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY END USER, CAGR (2020-2028)

FIGURE 39 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 41 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)

FIGURE 42 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)

FIGURE 43 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: SNAPSHOT (2020)

FIGURE 45 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020)

FIGURE 46 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 47 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 48 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY TYPE (2020-2028)

FIGURE 49 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: COMPANY SHARE 2020 (%)

查看详细信息

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

中东和非洲睡眠障碍治疗市场 – 行业趋势和 2028 年预测

通过敏捷供应链咨询解决关税挑战

市场分析与洞察：中东和非洲睡眠障碍治疗市场

睡眠障碍治疗市场范围和市场规模

中东和非洲睡眠障碍治疗市场国家级分析

竞争格局和睡眠障碍治疗市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

报告

市场洞察

支持

解决方案

中东和非洲睡眠障碍治疗市场 – 行业趋势和 2028 年预测

通过敏捷供应链咨询解决关税挑战

市场分析与洞察：中东和非洲睡眠障碍治疗市场

睡眠障碍治疗市场范围和市场规模

中东和非洲睡眠障碍治疗市场国家级分析

竞争格局和睡眠障碍治疗市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

浏览相关页面